Finally, our data demonstrate efficacy of pharmacological targeting of Nur77 given prophylactically to decrease UTI severity by limiting UPEC intracellular invasion and enhancing its clearance from the bladder. This evidence concerns the gene NR4A1 and bacterial urinary tract infection.